Amptiv Biosciences

United States
Cumberland Head, New York, United States, 44236

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Total equity funding
$200,000
Last funding
Pre Seed / $200,000 / 2024-12-18
Last equity funding
Pre Seed / $200,000
Investors
1

Founders and investors

Investors

Antler